Clin2
NCT05541042Possibly a fitNot yet recruiting

MRI and PET scan results matched to tumor gene markers

Glioblastoma

Part of Cancer clinical trials.

This study looks for connections between detailed brain scans and tumor genetic features in people with glioblastoma. It may help researchers find better ways to understand your tumor and tailor future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of glioblastoma based on lab tests on tissue from surgery
  • You had brain tumor surgery at Henan Provincial People’s Hospital, and a small reservoir was placed during surgery for later noninvasive fluid collection
  • You can safely complete the required CT and PET/CT scans
  • You can attend the scheduled study visits and follow study testing and treatment timing
  • Your general function score is 70 or higher (Karnofsky score)
  • You do not have serious uncontrolled illness or conditions that would interfere with study testing

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06113705Recruiting
Better MRI and blood tests for glioblastoma treatment response

This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.

Rozzano
NCT07461948Recruiting· Phase 3
Advanced imaging study for glioblastoma patients

This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.

Los Angeles, California
NCT06613841Recruiting· Early Phase 1
Brain tumor imaging study for glioblastoma patients

This study uses special PET scans (fluciclovine and FDG) and advanced MRI to create a detailed metabolic profile of glioblastoma. It may help doctors better understand your tumor before surgery.

Philadelphia, Pennsylvania
NCT06480721Not yet recruiting
Using FET-PET scans to guide treatment for possible pseudoprogression in glioblastoma

This trial uses a special type of PET scan (FET-PET) to help doctors distinguish between pseudoprogression (a temporary reaction to treatment that can look like tumor growth on MRI) and actual tumor recurrence in people with glioblastoma. The goal is to improve management decisions and avoid unnecessary treatments.

Amsterdam
NCT07735819Not yet recruiting· Phase 2
PET/CT scan for people with glioma

This study uses a special PET/CT scan to take detailed pictures of gliomas (a type of brain tumor). It may help doctors understand your tumor better and plan your treatment.

Detroit, Michigan
NCT06623565Recruiting
Advanced imaging for extensive brain tumor removal

This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.

Amsterdam, North Holland

Hear when a new Glioblastoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.